.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Harvard Business School
AstraZeneca
Moodys
Boehringer Ingelheim
Daiichi Sankyo
Accenture
Cerilliant
Julphar
Deloitte

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207500

« Back to Dashboard
NDA 207500 describes CRESEMBA, which is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the CRESEMBA profile page.

The generic ingredient in CRESEMBA is isavuconazonium sulfate. One supplier is listed for this compound. Additional details are available on the isavuconazonium sulfate profile page.

Summary for NDA: 207500

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Suppliers and Packaging for NDA: 207500

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CRESEMBA
isavuconazonium sulfate
CAPSULE;ORAL 207500 NDA Astellas Pharma US, Inc. 0469-0520 0469-0520-14 4 CARTON in 1 CARTON (0469-0520-14) > 14 BLISTER PACK in 1 CARTON > 1 CAPSULE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength186MG
Approval Date:Mar 6, 2015TE:RLD:Yes
Patent:► SubscribePatent Expiration:Oct 31, 2020Product Flag?Substance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Oct 31, 2020Product Flag?Substance Flag?YDelist Request?
Regulatory Exclusivity Expiration:Mar 6, 2025
Regulatory Exclusivity Use:GENERATING ANTIBIOTIC INCENTIVES NOW


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Chubb
Teva
Mallinckrodt
Farmers Insurance
Citi
Dow
Healthtrust
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot